BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with no assurance on timing, size, or terms.
Net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Offering Details
Shares of common stock (or pre-funded warrants) will be offered by BioSig Technologies, Inc.
Underwriters
Clear Street and Needham & Company are joint book-running managers of the offering.
Registration Statement
The offering is made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC on December 17, 2024.
- The completion of the offering is contingent on market conditions, indicating flexibility in timing and terms.
- The company's intention to purchase gold bullion highlights a strategic investment approach amidst market uncertainties.
BioSig Technologies' proposed public offering reflects its strategic use of capital for long-term growth and stability in uncertain market conditions.